skip main site navigation go to current site section navigation

Xeris Pharmaceuticals

XeriJect is a disruptive platform that addresses the problem of injection with a non-aqueous reformulation of existing biopharmaceuticals. This platform creates highly concentrated pastes or viscous liquids, which can be packaged into an auto-injector pen for rapid and easy administration. For severe hypoglycemia, Xeris has created a non-aqueous glucagon formulation to develop a Glucagon Rescue Pen (GRP) akin to the EpiPen for allergic reactions.

For more information, visit